May 17, 2022
New center opens in Suzhou New District, China, to bring local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug development SANTA ANA, California -- FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced [...]
May 17, 2022
Report outlines work done to date to advance priorities of Avantor's Science for Goodness sustainability platform RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today released its 2022 sustainability report highlighting the company's significant progress [...]
Forensic Laboratories Gain Unique Flexibility with Spectrum CE System
May 17, 2022
Long-anticipated instrument is compatible with any 5-, 6- or 8-color STR analysis chemistry Madison, WI USA. -- Forensics laboratories performing human identification in criminal casework and database cases have a new option for a capillary electrophoresis (CE) instrument to support their workflow. The Spectrum CE System, launched today by Promega, presents a new alternative in [...]
INDIGO Biosciences Offers New Assay to Test Development and Oncology Therapeutics
May 17, 2022
INDIGO Offers Human Estrogen-related Receptor Beta Assay as a Commercial Assay for the First Time State College, PA – INDIGO Biosciences, the recognized industry leader in nuclear receptor reporter assays, announced today the expanding of their robust preclinical testing portfolio of cell-based reporter assays to include the Human Estrogen-related Receptor Beta (NR3B2; ERRβ). This cell-based in vitro reporter assay provides [...]
PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing
May 16, 2022
Latest addition to Company’s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients WALTHAM, Mass. -- PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics. This addition to the Company’s portfolio of [...]
Aldevron Licenses the Manufacturing of a TYPE-V CRISPR Nuclease From Inscripta
May 16, 2022
A partnership between two CRISPR pioneers will provide the global scientific community with GMP MAD7™ Nuclease Aldevron®, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, along with Inscripta®, a life science technology company dedicated to making CRISPR-based genome engineering accessible to any research lab, [...]
May 13, 2022
Oxford Nanopore technology will enable the 1000 Genomes Project, spearheaded by researchers at the University of Washington and Seattle Children’s Hospital, to gain greater genomic insights into clinically relevant variants by providing accurate, affordable, scalable and comprehensive information Uncovering new discoveries across the genome Oxford Nanopore sequencing technology is to be used by a group [...]
May 13, 2022
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has secured a multi-year contract, following a competitive procurement, to work with three Finnish Hospital District owned Biobanks (Clinical Biobanks) on improving access to, and automated management of, phenotypic, genomic, and clinical data. The project underpins Finland’s ambition to be [...]
May 12, 2022
New Innovation Significantly Reduces Turnaround Time While Decreasing Manual and Error-Prone Steps INDIANAPOLIS – Creating the industry’s first stem cell analysis update in nearly 25 years, Beckman Coulter Life Sciences – a global leader in laboratory automation and innovation – launches an evolution of the gold standard in hematopoietic stem cell enumeration, the AQUIOS STEM System. [...]
May 12, 2022
CAMBRIDGE, Mass. -- Ultivue, Inc., an industry leader in multiplexing assays and analytics solutions for tissue biomarker studies, announced today multiple collaborations for AI-powered spatial phenomics solutions for translational research groups and Biopharma. Ultivue develops unique workflows for use in both multiplex immunofluorescence (mIF) imaging and spatial phenomics. Its proprietary InSituPlex® technology is designed for [...]

